Literature DB >> 17130877

Genetic testing for colon cancer.

Andrew M Kaz1, Teresa A Brentnall.   

Abstract

Colon cancer remains the third leading cause of death due to cancer in the US, where it affected more than 145,000 individuals in 2005. Up to 30% of these cases exhibit familial clustering, which means that tens of thousands of individuals have a disease with a potentially definable genetic component. Approximately 3-5% of colon cancers are associated with high-risk, inherited colon cancer syndromes. Identification of the genes that cause these colon cancer syndromes, coupled with additional insights into their clinical course, has led to the development of specific management guidelines--and genetic tests--that can diagnose these familial disorders. These guidelines can be life-saving, not only for the affected patient, but also for their family members.

Entities:  

Mesh:

Year:  2006        PMID: 17130877     DOI: 10.1038/ncpgasthep0663

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


  13 in total

Review 1.  Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach.

Authors:  Wei Chen; Minyong Chen; Larry S Barak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

2.  Underdiagnosis of Lynch syndrome involves more than family history criteria.

Authors:  Hardeep Singh; Rachel Schiesser; Gobind Anand; Peter A Richardson; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2010-03-18       Impact factor: 11.382

Review 3.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

4.  Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report.

Authors:  Anna V Hoekstra; J Julie Kim; Pacita Keh; Julian C Schink
Journal:  J Reprod Med       Date:  2008-11       Impact factor: 0.142

5.  Aneuploidy of chromosome 8 and mutation of circulating tumor cells predict pathologic complete response in the treatment of locally advanced rectal cancer.

Authors:  Jue-Feng Wan; Xue-Qin Li; Jing Zhang; Li-Feng Yang; Ji Zhu; Gui-Chao Li; Li-Ping Liang; Li-Jun Shen; Hui Zhang; Jing Li; Yi-Tong Zhang; Chang-Yue Chen; Zhen Zhang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

6.  Adenomatous polyposis in a young jamaican male of african descent.

Authors:  R Alfred; M Mills
Journal:  West Indian Med J       Date:  2014-04-11       Impact factor: 0.171

7.  Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.

Authors:  Robert Cook-Deegan; Christopher DeRienzo; Julia Carbone; Subhashini Chandrasekharan; Christopher Heaney; Christopher Conover
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

8.  Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.

Authors:  Angelo A Izzo; Gabriella Aviello; Stefania Petrosino; Pierangelo Orlando; Giovanni Marsicano; Beat Lutz; Francesca Borrelli; Raffaele Capasso; Santosh Nigam; Francesco Capasso; Vincenzo Di Marzo
Journal:  J Mol Med (Berl)       Date:  2007-09-06       Impact factor: 4.599

9.  Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG.

Authors:  Bo Zhang; Xukai Wang; Yan Wang
Journal:  J Exp Clin Cancer Res       Date:  2009-04-28

10.  Next-generation sequencing for genetic testing of familial colorectal cancer syndromes.

Authors:  Michele Simbolo; Andrea Mafficini; Marco Agostini; Corrado Pedrazzani; Chiara Bedin; Emanuele D Urso; Donato Nitti; Giona Turri; Maria Scardoni; Matteo Fassan; Aldo Scarpa
Journal:  Hered Cancer Clin Pract       Date:  2015-08-21       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.